Skip to main navigation
  • Recent News
  • Investors
  • Contact Us
Avadel pharmaceutical logo
  • Home
  • About Us
  • Our Focus
  • Culture & Careers
  • Recent News
  • Investors
  • Contact Us

Breadcrumb

  1. Home
  2. Investors
  3. SEC Filings
  4. DEF 14A

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Apr 27, 2020
Document Date
Aug 5, 2020
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Avadel Pharmaceuticals PLC
Issuer
AVADEL PHARMACEUTICALS PLC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • About Us
  • Our Focus
  • Culture & Careers
  • Recent News
  • Investors
  • Contact Us
  • Home
  • About Us
  • Our Focus
  • Culture & Careers
  • Contact Us
  • Recent News
  • Investors
  • Privacy Policy
  • Corporate Compliance
  • Terms and Conditions

Avadel, the Avadel logo, the droplet brand mark, and other brands are trademarks of an Avadel company. © 2022 Avadel. All rights reserved.

PM-US-AVGEN-0132

We Care About Your Privacy

This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our updated Privacy Policy.

You are about to leave the Avadel website.

Do you want to continue?

Avadel is not responsible for the content or availability of third party sites.